Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Med Chem ; 63(20): 11448-11468, 2020 10 22.
Artículo en Inglés | MEDLINE | ID: mdl-32614585

RESUMEN

Extracellular adenosine (ADO), present in high concentrations in the tumor microenvironment (TME), suppresses immune function via inhibition of T cell and NK cell activation. Intratumoral generation of ADO depends on the sequential catabolism of ATP by two ecto-nucleotidases, CD39 (ATP → AMP) and CD73 (AMP → ADO). Inhibition of CD73 eliminates a major pathway of ADO production in the TME and can reverse ADO-mediated immune suppression. Extensive interrogation of structure-activity relationships (SARs), structure-based drug design, and optimization of pharmacokinetic properties culminated in the discovery of AB680, a highly potent (Ki = 5 pM), reversible, and selective inhibitor of CD73. AB680 is further characterized by very low clearance and long half-lives across preclinical species, resulting in a PK profile suitable for long-acting parenteral administration. AB680 is currently being evaluated in phase 1 clinical trials. Initial data show AB680 is well tolerated and exhibits a pharmacokinetic profile suitable for biweekly (Q2W) iv-administration in human.


Asunto(s)
5'-Nucleotidasa/antagonistas & inhibidores , Descubrimiento de Drogas/métodos , Bibliotecas de Moléculas Pequeñas/síntesis química , 5'-Nucleotidasa/genética , Animales , Sitios de Unión , Linfocitos T CD8-positivos/efectos de los fármacos , Linfocitos T CD8-positivos/metabolismo , Proteínas Ligadas a GPI/antagonistas & inhibidores , Proteínas Ligadas a GPI/genética , Haplorrinos , Humanos , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/metabolismo , Ratones , Modelos Moleculares , Unión Proteica , Ratas , Bibliotecas de Moléculas Pequeñas/química , Bibliotecas de Moléculas Pequeñas/farmacocinética , Bibliotecas de Moléculas Pequeñas/farmacología , Relación Estructura-Actividad
2.
Org Chem Front ; 3(10): 1228-1235, 2016 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-28239480

RESUMEN

A full account of our investigation of C-C bond migration in the cycloisomerization of oxygen-tethered 1,6-enynes is described. Under Pt(II) and/or Ir(I) catalysis, cyclic and acylic alkyl groups were found to undergo 1,2-shifts into metal carbenoid intermediates. Interestingly, this process does not appear to be driven by the release of ring strain, and thus provides access to large carbocyclic frameworks. The beneficial effect of CO on the Pt(II) and Ir(I) catalytic systems is also evaluated.

3.
J Am Chem Soc ; 138(1): 108-11, 2016 Jan 13.
Artículo en Inglés | MEDLINE | ID: mdl-26716762

RESUMEN

The first total synthesis of (±)-gelsenicine is reported. The synthetic route is highly efficient (13 steps), featuring (1) a pivotal metal-catalyzed isomerization/rearrangement process that forges the central core of the molecule and (2) two facile C-N bond-forming steps that establish the flanking heterocycles.


Asunto(s)
Alcaloides Indólicos/síntesis química , Catálisis , Ciclización , Isomerismo
4.
Chem Commun (Camb) ; 50(40): 5239-41, 2014 May 25.
Artículo en Inglés | MEDLINE | ID: mdl-24296545

RESUMEN

A C-C bond migration event during the cycloisomerization of 1,6-enynes is described. Two different catalytic systems, iridium- or platinum-based, are able to induce this process. Alkyl migrations of larger rings and acyclic groups indicate that the reaction is not fully driven by the release of ring strain.

5.
Org Lett ; 15(7): 1772-5, 2013 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-23528017

RESUMEN

Enantiospecific cycloisomerizations of 1,6-enynes to form oxabicyclo[4.1.0]heptene derivatives are described. Enantiospecificity is consistently high regardless of alkene or alkyne substitution, providing a general approach to greatly enantioenriched cyclopropanes. Additionally, a model for stereochemical transfer is proposed.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA